GluK1-GluK3 are low affinity KAR subunits, due to relatively high concentration of agonist needed for their activation (K D for [ 3 H]kainate, 50100 nM) compared to GluK4 and GluK5 which are high affinity subunits (K D for [ 3 H]kainate, 5 nM) (Figure 1B)
Summary: This preclinical study investigated the mechanism of action of Cagrilintide in animal models
Can it help with other skin problems
Espe M, Lai F, Gomes AS, De Santis C, Hartviksen MB, Holen E, Rnnestad I
So, how does GAINSWave help
In published pre-clinical studies, both peptides are most commonly administered via subcutaneous (SubQ) or intramuscular (IM) injection